Bearish Gap Down for Pinetree Capital Ltd After Worse Fundamentals

 Bearish Gap Down for Pinetree Capital Ltd After Worse Fundamentals

The stock of Pinetree Capital Ltd (TSE:PNP) gapped down by $0.01 today and has $2.34 target or 14.00% below today’s $2.72 share price. The 7 months technical chart setup indicates high risk for the $12.26 million company. The gap down was reported on Nov, 14 by Barchart.com. If the $2.34 price target is reached, the company will be worth $1.72M less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. About 24,399 shares traded hands or 419.13% up from the average. Pinetree Capital Ltd (TSE:PNP) has declined 7.00% since April 8, 2016 and is downtrending. It has underperformed by 11.98% the S&P500.

More notable recent Pinetree Capital Ltd (TSE:PNP) news were published by: Marketwatch.com which released: “Pinetree Capital Ltd. Provides Update of Its Beneficial Ownership of Common …” on August 26, 2016, also Marketwatch.com with their article: “Pinetree Capital Ltd. Announces Completion of Share Consolidation” published on July 20, 2016, Midasletter.com published: “Pinetree Capital Ltd. CEO Sheldon Inwentash is Out in Default-induced Board …” on January 26, 2015. More interesting news about Pinetree Capital Ltd (TSE:PNP) were released by: Marketwired.com and their article: “Pinetree Capital Ltd. Announces Effective Date of Share Consolidation and …” published on July 14, 2016 as well as Pehub.com‘s news article titled: “Susan Fox replaces Carmelo Marrelli as CFO of Pinetree Capital” with publication date: May 13, 2016.

Pinetree Capital Ltd. is an investment and merchant banking firm focused on the small-cap market, with early-stage investments in resource, biotechnology and technology companies. The company has a market cap of $12.26 million. The Company’s investment portfolio includes equities, warrants, and promissory notes and convertible debentures. It currently has negative earnings. The Company’s geographical segment is Canada.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment